Cargando…

COVID-19 in Hematologic Malignancies: Big Challenges

Detalles Bibliográficos
Autores principales:	Hu, Yongxian, Wang, Linqin, Cui, Qu, Su Yin, Elaine Tan, Wu, Hengwei, Nagler, Arnon, Huang, He
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Atlantis Press 2020
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432404/ https://www.ncbi.nlm.nih.gov/pubmed/34595459 http://dx.doi.org/10.2991/chi.k.200919.001

Ejemplares similares

Weathering the storm: COVID-19 infection in patients with hematological malignancies
por: Wang, Lin-qin, et al.
Publicado: (2020)

CAR T-cell treatment during the COVID-19 pandemic: Management strategies and challenges
por: Hu, Yongxian, et al.
Publicado: (2020)

CAR-T cell therapy-related cytokine release syndrome and therapeutic response is modulated by the gut microbiome in hematologic malignancies
por: Hu, Yongxian, et al.
Publicado: (2022)

Serial surveillance by circulating tumor DNA profiling after chimeric antigen receptor T therapy for the guidance of r/r diffuse large B cell lymphoma precise treatment
por: Zhou, Linghui, et al.
Publicado: (2021)

Practicing Clinical Hematology During the COVID-19 Outbreak: A Challenge Like No Other
por: Mohty, Mohamad, et al.
Publicado: (2020)

Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India
por: Jain, Arihant, et al.
Publicado: (2022)

The Role of Measurable Residual Disease (MRD) in Hematopoietic Stem Cell Transplantation for Hematological Malignancies Focusing on Acute Leukemia
por: Czyz, Anna, et al.
Publicado: (2019)

Clinical Hematology International: Why a New Journal in Hematology?
por: Mohty, Mohamad, et al.
Publicado: (2019)

Cytokine release syndrome was an independent risk factor associated with hypoalbuminemia for patients with relapsed/refractory hematological malignancies after CAR-T cell therapy
por: Ding, Shuyi, et al.
Publicado: (2023)

Targeting TIM-3 for hematological malignancy: latest updates from the 2022 ASH annual meeting
por: Tan, Jiaxiong, et al.
Publicado: (2023)

High mortality with High false negative rate: COVID-19 infection in patients with hematologic malignancies()
por: Niu, Alex, et al.
Publicado: (2021)

Development of expression-based biomarkers of Dasatinib response in hematologic malignancies
por: Akre, Monica K., et al.
Publicado: (2017)

Novel cellular immunotherapies for hematological malignancies: recent updates from the 2021 ASH annual meeting
por: Wang, Ji-nuo, et al.
Publicado: (2022)

CAR-NK cell therapy for hematological malignancies: recent updates from ASH 2022
por: Huang, Ruihao, et al.
Publicado: (2023)

Reinfection versus failure of viral clearance in a COVID-19 patient with hematologic malignancy
por: Ibrahim, Moayed, et al.
Publicado: (2021)

Extracorporeal membrane oxygenation support in patients with hematologic malignancies: to whom and when?
por: Hong, Junshik, et al.
Publicado: (2017)

Characteristics of pathogens detected in adults with hematological malignancies and nosocomial infections in the tropics
por: Dou, Li-Ping, et al.
Publicado: (2020)

Survival trends in hematological malignancies in the Nordic countries through 50 years
por: Hemminki, Kari, et al.
Publicado: (2022)

Potential role of STAG1 mutations in genetic predisposition to childhood hematological malignancies
por: Saitta, Claudia, et al.
Publicado: (2022)

Profile of capillary-leak syndrome in patients received chimeric antigen receptor T cell therapy
por: Feng, Jingjing, et al.
Publicado: (2022)

The emerging landscape of exosomal CircRNAs in solid cancers and hematological malignancies
por: Zhou, Qinfeng, et al.
Publicado: (2022)

The big challenge for neurologists in treating patients with multiple sclerosis in the post-COVID-19 era
por: Naser Moghadasi, Abdorreza
Publicado: (2020)

Looking Ahead: Clinical Hematology International Turns One
por: Mohty, Mohamad, et al.
Publicado: (2020)

Diagnostic Challenges of CD4(+)/CD56(+)/CD123(+) hematological neoplasms
por: Thiago, Leandro S., et al.
Publicado: (2013)

Video-assisted thoracic surgery for ambiguous lung or mediastinal masses in response assessments for hematological malignancies
por: Zheng, Runhui, et al.
Publicado: (2022)

Immunotherapy in hematologic malignancies: achievements, challenges and future prospects
por: Tang, Lu, et al.
Publicado: (2023)

Multiomics of three hematological malignancies in a patient reveal their origin from clonal hematopoietic stem cells
por: Mayeur, Sylvain, et al.
Publicado: (2023)

Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry
por: Marchesi, Francesco, et al.
Publicado: (2023)

NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies
por: Patkar, Nikhil, et al.
Publicado: (2020)

Outcome of infection with omicron SARS‐CoV‐2 variant in patients with hematological malignancies: An EPICOVIDEHA survey report
por: Blennow, Ola, et al.
Publicado: (2022)

Successful BCMA CAR-T Therapy for Multiple Myeloma With Central Nervous System Involvement Manifesting as Cauda Equina Syndrome—A Wandering Road to Remission
por: Wang, Yiyun, et al.
Publicado: (2021)

Big Stones
por: Milton, F.
Publicado: (1914)

Big Tongue
por: Thornton, J. Frank
Publicado: (1897)

That Big Tongue
por: Jackson, Edward B.
Publicado: (1897)

COVID-19 outcomes in patients with hematologic disease
por: Malard, Florent, et al.
Publicado: (2020)

A retrospective comparison of CD19 single and CD19/CD22 bispecific targeted chimeric antigen receptor T cell therapy in patients with relapsed/refractory acute lymphoblastic leukemia
por: Wang, Yiyun, et al.
Publicado: (2020)

The Challenge of Targeting Notch in Hematologic Malignancies
por: Hernandez Tejada, Fiorela N., et al.
Publicado: (2014)

Abatacept for graft versus host disease prophylaxis in patients 60 years and older receiving mismatched unrelated donor transplantation for hematologic malignancies
por: Raghunandan, Sharmila, et al.
Publicado: (2023)

Deubiquitinases in hematological malignancies
por: Lei, Hu, et al.
Publicado: (2021)

The challenges of big data
por: Mardis, Elaine R.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_o6vl49otnub4mh8ibf0u1ak1fm